SCHEMBL7684558

SCHEMBL7684558

COC(=O)CCn1c(C(=O)O)cc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ POLB P06746 1/20 0.61
▸ CCR2 P41597 4/20 0.57
▸ MCL1 Q07820 4/20 0.55
▸ MTNR1A P48039 1/20 0.52
▸ MTNR1B P49286 1/20 0.52
▸ DAO P14920 1/20 0.49
▸ TSHR P16473 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ CNR2 P34972 3/20 0.46
▸ CTNNB1 P35222 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2480710 0.91 ALDH1A1 (0.57) ALDH1A1CYP1A2POLBCCR2MCL1
SCHEMBL29937398 0.89 MTNR1A (0.65) ALDH1A1CYP1A2POLBMTNR1AMTNR1B
SCHEMBL6701625 0.86 ALDH1A1 (0.59) ALDH1A1CYP1A2POLBCCR2MCL1
SCHEMBL2476665 0.86 CCR2 (0.60) ALDH1A1CYP1A2POLBCCR2MCL1
Hydrochloric Acid SCHEMBL9085791 0.84 ALDH1A1 (0.59) ALDH1A1CYP1A2POLBCCR2MCL1
SCHEMBL7682421 0.84 MTNR1A (0.51) ALDH1A1CYP1A2POLBCCR2MTNR1A
SCHEMBL11681610 0.83 KDM4E (0.62) ALDH1A1CYP1A2POLBTSHRHTT
SCHEMBL29750342 0.83 ALDH1A1 (0.64) ALDH1A1CYP1A2POLBCCR2MCL1
SCHEMBL7894118 0.83 ALDH1A1 (0.64) ALDH1A1CYP1A2POLBCCR2MCL1
SCHEMBL700800 0.81 ALDH1A1 (0.69) ALDH1A1CYP1A2POLBCCR2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380230-B1 FOR THERAPY OF DYSKINESIA, OBESITY, IRRITABLE BOWEL SYNDROME, DISEASES WHOSE TREATMENT REQUIRES STIMULATION OF THE CHOLECYSTOKININ CCK-A RECEPTORS SANOFI-SYNTHELABO (FR) 2002-04-30 — — US disclosed
CN-1276790-A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them SANOFI SA (FR) 2000-12-13 — — CN disclosed
US-5760032-A GASTROINTESTINAL DISORDERS AND NERVOUS SYSTEM DISORDERS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-06-02 — — US disclosed
EP-0776892-A1 THIENYLAZOLE COMPOUND AND THIENOTRIAZOLODIAZEPINE COMPOUND YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-06-04 — — EP disclosed
Send feedback